Some experiments revealed attenuation of NLRP3-mediated neuroinflammation in PD mouse models using peroxisome proliferator-activated receptor beta/delta (PPAR-β/δ) agonist GW501516 (Figure 3, Table 2). Here, PPARD is linked to Parkinson disease.